Dataset Information

Considering Performance in the Automated and Manual Coding of Sociolinguistic Variables: Lessons From Variable (ING).

ABSTRACT: Impressionistic coding of sociolinguistic variables like English (ING), the alternation between pronunciations like talkin' and talking, has been a central part of the analytic workflow in studies of language variation and change for over a half-century. Techniques for automating the measurement and coding for a wide range of sociolinguistic data have been on the rise over recent decades but procedures for coding some features, especially those without clearly defined acoustic correlates like (ING), have lagged behind others, such as vowels and sibilants. This paper explores computational methods for automatically coding variable (ING) in speech recordings, examining the use of automatic speech recognition procedures related to forced alignment (using the Montreal Forced Aligner) as well as supervised machine learning algorithms (linear and radial support vector machines, and random forests). Considering the automated coding of pronunciation variables like (ING) raises broader questions for sociolinguistic methods, such as how much different human analysts agree in their impressionistic codes for such variables and what data might act as the "gold standard" for training and testing of automated procedures. This paper explores several of these considerations in automated, and manual, coding of sociolinguistic variables and provides baseline performance data for automated and manual coding methods. We consider multiple ways of assessing algorithms' performance, including agreement with human coders, as well as the impact on the outcome of an analysis of (ING) that includes linguistic and social factors. Our results show promise for automated coding methods but also highlight that variability in results should be expected even with careful human coded data. All data for our study come from the public Corpus of Regional African American Language and code and derivative datasets (including our hand-coded data) are available with the paper.

SUBMITTER: Kendall T

PROVIDER: S-EPMC8117961 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:The manual Generation II (Gen II) ELISA method used to measure Anti-Müllerian Hormone (AMH) from Beckman Coulter has recently been superseded by a fully automated AMH immunoassay. The aim of this study was to evaluate the performance of the Access AMH assay and directly compare it to the modified Gen II ELISA method. A secondary aim was to verify that the fertile age-related AMH range previously established using the Gen II ELISA could be used to interpret results from the new automated Access assay.The precision, stability, linearity, measurement range and detection limits were determined using recombinant AMH and patient serum samples. Different diluents and their effects on AMH concentration were compared. A correlation study was performed on patient samples to compare the Access AMH assay to the ELISA method on the Access2 and DxI800 analysers. The fertile AMH range was verified by comparing the 10th, 50th and 90th percentile values from both methods obtained from 489 natural conception pregnant women.The Access AMH assay showed good performance across the measuring range for both intra-assay (CV 1.41-3.30 %) and inter-assay (CV 3.04-5.76 %) precision and acceptable sample stability. Dilution of the high concentration samples with the recommended diluent resulted in a small but significant downward shift in values. The assay was linear over the range of values recommended by the manufacturer, allowing for accurate reporting within the reported range. The two assay types were highly correlated (R(2)?=?0.9822 and 0.9832 for Access2 and DxI800, respectively), and the differences observed between the Access2 and DxI800 analysers were within clinically acceptable ranges, indicating that the methods are interchangeable. Furthermore, we demonstrated that results from the published reference range for the Gen II ELISA correlate with those from the automated Access AMH assay.Here, we verified the published performance of the Access AMH assay and showed excellent correlation with the Gen II ELISA method. Moreover, we validated this correlation by confirming that the results from a fertile AMH reference range established using the preceding Gen II ELISA are interchangeable with the new automated Access AMH assay.

Project description:Fabry disease, an X-linked lysosomal storage disorder caused by galactosidase alpha (GLA) gene mutations, exhibits diverse clinical manifestations, and poses significant diagnostic challenges. Early diagnosis and treatment are crucial for improved patient outcomes, pressing the need for reliable biomarkers. In this study, we aimed to identify miRNA candidates as potential biomarkers for Fabry disease using the KingFisher™ automated isolation method and NanoString nCounter® miRNA detection assay. Clinical serum samples were collected from both healthy subjects and Fabry disease patients. RNA extraction from the samples was performed using the KingFisher™ automated isolation method with the MagMAX mirVana™ kit or manually using the Qiagen miRNeasy kit. The subsequent NanoString nCounter® miRNA detection assay showed consistent performance and no correlation between RNA input concentration and raw count, ensuring reliable and reproducible results. Interestingly, the detection range and highly differential miRNA between the control and disease groups were found to be distinct depending on the isolation method employed. Nevertheless, enrichment analysis of miRNA-targeting genes consistently revealed significant associations with angiogenesis pathways in both isolation methods. Additionally, our investigation into the impact of enzyme replacement therapy on miRNA expression indicated that some differential miRNAs may be sensitive to treatment. Our study provides valuable insights to identify miRNA biomarkers for Fabry disease. While different isolation methods yielded various detection ranges and highly differential miRNAs, the consistent association with angiogenesis pathways suggests their significance in disease progression. These findings lay the groundwork for further investigations and validation studies, ultimately leading to the development of non-invasive and reliable biomarkers to aid in early diagnosis and treatment monitoring for Fabry disease.

Dataset Information

Considering Performance in the Automated and Manual Coding of Sociolinguistic Variables: Lessons From Variable (ING).

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets